Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

By M. Marin, Dalya Güriş, S. Chaves, S. Schmid, J. Seward. MMWR Recommendations and Reports, 2007

1,298 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplant Recipients: A Global Perspective (2009, background): “All HCT candidates and recipients, particularly those who are VZV seronegative, should be informed of the potential seriousness of VZV disease among immunocompromised persons and advised of strategies to decrease their risk for VZV exposure (AII) [282].”
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. (2014, background): “e Consider if the patient is not severely immunosuppressed AND the patient is varicella immune as defined by documentation of age-appropriate varicella vaccination, serologic evidence of immunity, documentation of varicella or zoster infection, or birth in the United States before 1980 [45] AND ther”
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. (2014, background): “Varicella Vaccination ACIP recommends varicella vaccination for HIV-positive children with mild to moderate immune suppression based on safety data [45, 79, 256].”